PainReform Ltd. (PRFX)
Automate Your Wheel Strategy on PRFX
With Tiblio's Option Bot, you can configure your own wheel strategy including PRFX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRFX
- Rev/Share 0.0
- Book/Share 3.9769
- PB 0.3043
- Debt/Equity 0.0066
- CurrentRatio 1.5916
- ROIC -0.4724
- MktCap 2435901.0
- FreeCF/Share -2.8073
- PFCF -0.4087
- PE -0.6287
- Debt/Assets 0.005
- DivYield 0
- ROE -0.7959
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
PainReform Provides Business Update for the Six Months Ended June 30, 2025
Published: October 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today provided a business update for the six months ended June 30, 2025.
Read More
Nvidia enrollment sends this stock soaring 130%
Published: August 19, 2025 by: Finbold
Sentiment: Positive
Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program.
Read More
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
Published: May 27, 2025 by: PRNewsWire
Sentiment: Neutral
As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost TEL AVIV, Israel , May 27, 2025 /PRNewswire/ -- Blade Ranger Ltd. (TASE: BLRN), a company listed on the Tel Aviv Stock Exchange, announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform (NASDAQ: PRFX).
Read More
PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
Published: March 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation
Read More
About PainReform Ltd. (PRFX)
- IPO Date 2020-09-01
- Website https://www.painreform.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Ehud Geller
- Employees 2